Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Yuan Xu Insider Profile
4 Followers
Yuan Xu, Director at Akero Therapeutics, holds ― shares in Akero Therapeutics (Ticker: AKRO), holds 8.67K shares in Fate Therapeutics (Ticker: FATE), holds ― shares in Xilio Therapeutics (Ticker: XLO). Most recently, Yuan Xu ― shares of Akero Therapeutics on ― for an estimated value of ―.
Yuan Xu has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Yuan Xu holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Yuan Xu
Yuan Xu's Trading History
Akero Therapeutics
―
Director
―
―
Fate Therapeutics
Aug 07, 2024
Director
Uninformative Sell
2.68K
$14.30K
Xilio Therapeutics
―
Director
―
―
List of latest transactions for each holding click on a transaction to see Yuan Xu's performance on stock
You May Also Like
Yuan Xu insider profile FAQ
What is the percentage of profitable transactions made by Yuan Xu?
The percentage of profitable transactions made by Yuan Xu is ―.
What is the average return per transaction made by Yuan Xu?
The average return per transaction made by Yuan Xu is ―.
What stocks does Yuan Xu hold?
Yuan Xu holds: AKRO, FATE, XLO stocks.
What was Yuan Xu’s latest transaction?
Yuan Xu latest transaction was an Uninformative Buy of ―.
What was Yuan Xu's most profitable transaction?
Yuan Xu’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Yuan Xu's role in Akero Therapeutics?
Yuan Xu's role in Akero Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.